Phase 3 trials for the malaria vaccine have been completed in Oxford, Serum.
The third and final phase of clinical trials for a new malaria vaccine has been completed in Oxford, United Kingdom. The vaccine, developed by Serum Institute of India, is said to be the most effective malaria vaccine to date.
The clinical trial involved over 1,500 children aged 5-17 months, who were given the vaccine or a placebo. The trial was conducted in seven different countries, including Ghana, Kenya, and Malawi.
The vaccine was found to be safe and effective, with no serious side effects reported. The vaccine will now be submitted for regulatory approval.
This is great news for the fight against malaria, which is a major problem in many parts of the world. With this new vaccine, we may finally be able to eradicate this disease once and for all.
Group Media Publications
General News Platform – https://ihtlive.com/
Entertainment News Platforms – anyflix.in
Construction Infrastructure and Mining News Platform – https://cimreviews.com/
Podcast Platforms – https://anyfm.in/